St. Paul records the second death from monkeypox

St. Paul records the second death from monkeypox


From Santos, the 36-year-old patient was admitted to Praia Grande and presented with comorbidities; with a new record, the country adds seven deaths from illness

São Paulo recorded, on Saturday 15, the second death of monkeypox. According to what was reported by the Secretary of State for Health, born in Santos, the 36-year-old patient had comorbidities and was hospitalized in Praia Grande since the beginning of September.

or The first death in the state was recorded on Wednesday12. A 26-year-old resident in the capital, according to the ministry had “various comorbidities”.

In the country there are 8,652 confirmed cases of the disease and six deaths, according to data from the Ministry of Health released on Friday 14th. However, the bulletin considers only the first victim of the disease in São Paulo. Therefore, the total number of deaths should be seven. Minas Gerais (3) and Rio (2) represent the remaining dead.

São Paulo, in turn, has 3,901 cases, according to the Ministry of Health. The secretariat underlines that, in the current outbreak, the “transmission of intimate and sexual contact” prevails.

The Pan American Health Organization warned him on Wednesday 12 four health emergencies threaten the Americas region: cholera, polio, covid-19 and monkeypox. Speaking of the latter, the director of PAHO, Carissa Etienne, stressed that the spread “seems to be slowing down”, even if last week more than 2,300 new infections were reported from the countries that make up the region.

Earlier this month, the Ministry of Health received the first 9,800 shipment of monkeypox vaccines. Brazil has purchased approximately 50,000 immunizers through the Pan American Health Organization (PAHO) revolving fund. The next batches are expected to be delivered by the end of 2022.

For now, as a guide from the World Health Organization (WHO), immunizers will be used to conduct studies. The research will serve to generate “evidence on the efficacy, immunogenicity and safety” of the monkeypox vaccine and, in this way, guide the decision of the managers, according to the Ministry of Health.

The file reinforces the fact that vaccines are safe and are currently being used against smallpox or common smallpox.

+The best content in your email for free. Choose your favorite Earth Newsletter. Click here!

Source: Terra

You may also like